News | November 20, 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis
Read More
News | November 5, 2018
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering
Read More
Press Release | July 16, 2018
Pliant Therapeutics Raises $62 Million in Series B Financing
Read More
Press Release | July 16, 2018
Verge Genomics Announces $32 Million Series A
Read More
